[1] MEDZHITOV R,PRESTON-HURBURT P,JANEWAY C A.A human homologue of the Drosophila Toll protein signals activation of adaptor immunity[J]. Nature,1997,388:394-400. [2] ROCK F L,HARDIUM G,TIMANS J C,et al.A family of human receptors structurally related to Drosophila Toll[J].Proc Natl Acad Sci USA,1998,95(2):588-593. [3] TAKEDA K,AKIRA S.Toll-like receptors in innate immunity[J]. Int Immunol,2005,17(1):1-14. [4] UENISHI H,SHINKAI H.Porcine Toll-like receptors:The front line of pathogen monitoring and possible implications for disease resistance[J]. Dev Comp Immunol,2009,33(3):353-361. [5] SHARMA B S,LEYVA I,SCHENKEL F,et al.Association of toll like receptor 4 polymorphisms with somatic cell score and lactation persistency in Holstein bulls[J]. J Dairy Sci,2006, 89(9):3626-3635. [6] WERLING D,HOPE J C,HOWARD C J,et al.Differential production of cytokines,reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with toll-like receptor agonists[J]. Immunology,2004,111:41-52. [7] JANEWAY JR C A,MEDZHITOV R. Innate immune recognition[J]. Annu Rev Immunol,2002,20:197-216. [8] BOCHUD P Y,HERSBERGER M,TAFFÉ P,et al.Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection[J]. AIDS,2007,21:441-446. [9] SHINKAI H,TANAKA M,MOROZUMI T,et al.Biased distribution of single nucleotide polymorphisms(SNPs) in porcine Toll-like receptor 1 (TLR1), TLR2, TLR4, TLR5, and TLR6 genes[J]. Immunogenetics,2006,58:324-330. [10] CARRINGTON M,NELSON G W,MARTIN M P,et al.HLA and HIV-1:Heterozygote advantage and B*35-Cw*04 disadvantage[J]. Science,1999,283:1748-1752. [11] FUJITA M,INTO T,YASUDA M,et al.Involvement of leucine residues at positions 107,112, and 115 in a leucine-rich repeat motif of human Toll-like receptor 2 in the recognition of diacylated lipoproteins and lipopeptides and Staphylococcus aureus peptidoglycans[J]. J Immunol,2003,171:3675-3683. [12] SMIRNOVA I,HAMBLIN M T,MCBRIDE C,et al.Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans[J]. Genetics,2001,158:1657-1664. [13] POLTORAK A,HE X L,SMIRNOVA I.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:Mutations in TLr4 gene[J].Science,1998,282:2085-2088. [14] PUTHOTHU B,FORSTER J,HEINZMANN A,et al.TLR4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J]. Dis Markers,2006,22(5-6):303-308. [15] ACHYUT B R.Association of Toll-like receptor-4(Asp299Gly and Thr399Ileu)gene polymorphisms with gastritis and precancerous lesions[J]. Human Immunology,2007,10(6):1-7. [16] BJORKBACKA H,KUNJATHOOR V V,MOORE K J,et al.Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling path ways[J].Nat Med,2004,10:416-421. [17] GIBOT S,CARIOU A,DROUET L,et al.Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate[J].Crit Care Med,2002, 30:969-973. [18] MICHELSEN K S,WONG M H,SHAH P K,et al.Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient inapolipoprotein E[J].Proc Natl Acad Sci USA,2004, 101:10679-10684. [19] LORENZ E,MIRA J P,FREES K L,et al.Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock[J]. Arch Intern Med,2002,162(9):1028-1032. [20] ARBOUR N C,LORENZ E,SCHUTTE B C,et al.TLR4 mutations are associated with endotoxin hyporesponsiveness in humans[J]. Nat Genet,2000,25(2):187-191. |